Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Samer Ellahham,

Samer Ellahham,

cardiovascular consoltancy UAE

yoshiaki  omura

yoshiaki omura

Newyork medical college USA

Masahura onuma

Masahura onuma

japan university of agriculture and technology Japan

Muhammad  Dookhun

Muhammad Dookhun

Hospital of nanjing medical college and university. Mauritius

HYPERTENSION CONGRESS 2020

About Conference


Conference series llc LTD is gratified to organize continuing medical education (CME) accredited event 4thInternational Conference on Hypertension & Healthcare” scheduled on March 25-26, 2020 at Tokyo, Japan the place which has the great influx of tourists. The conference mainly runs on the theme “Exploring the new horizons to cure Hypertension & Cardiac diseases “we bring together the brightest and most prolific minds to discuss the interesting concepts of Hypertension and Healthcare diagnosis and management using the modern techniques at Hypertension Congress 2020.

Hypertension congress 2020 mainly  aims to provide an prospect to share the knowledge regarding the Hypertension conference among the large number of medical professionals like , Scientists, Professors , Cardiologists, Researchers, Deans Heads, Directors, and Founders or Writers  and Employees of the related companies of the Hypertension and Healthcare, Cardiology and related departments, Organizations, Associations, Laboratory members and Young researchers working in the field of hypertension treatment and Healthcare management. This conference mainly focuses on spreading awareness about the challenges in the field of related hypertension and Healthcare.  This Hypertension Congress or rather all Hypertension conference gathering, cardiology events, and Hypertension Conference will help in frameworks organization, B2B uniting amidst specialists, researchers, and academicians. 

Target Audience:

  • Directors of Hypertension or related Programs or Associations
  • Heads, Deans and Professors of Hypertension or Cardiology departments
  • Scientists and Researchers organizers
  • Doctors
  • Medical Colleges
  • Writers
  • Healthcare professionals
  • Founders and Employees of the related companies
  • Clinical investigators
  • Hospitals and Health Services
  • Pharmaceutical companies
  • Laboratory members
  • Training institutions
  • Support organizers
  • Data Management Companies
  • Cardiologists training and education
  • Nurse and nursing education institutions

Why attend?

Encountering the target market with members from across the globe, committed to learning about hypertension treatment and Healthcare management. This is the best opportunity to reach the largest gathering of participants from around the world. Conduct presentations distribute and update knowledge about the current situation of hypertension treatment at Hypertension Conference. Exchange of views and knowledge regarding Hypertension and health care leads to the more innovative thoughts that will pay a way to reduce the risk of occurrence and spread awareness among the people. World-eminent speakers, most recent researches, latest treatment techniques and advanced updates in Hypertension Treatment and Management   are the principal feature of Hypertension Congress 2020.

Session/ Tracks

Track 1:  Hypertension

 The disorder where the blood pressure in the arteries is persistently raised at a constant rate. This is also called as high blood pressure or high vital sign or blood vessel cardiovascular disease. This session categories of  cardiovascular disease. The primary disease and secondary disease. Almost 90-95 % of cases are primary and the main cause behind it is the unhealthy lifestyle followed by excessive consumption of alcohol, salt, body weight etc. Remaining 5-10% of individuals suffer this due to thinning of kidney arteries, chronic kidney diseases, and endocrine disorder . Assessment of cardiovascular disease primarily includes Confirmation of hypertension, Risk factors, Fundamental causes, organ injury & Indications and contraindications of medication. Hypertension could be a major threat issue for cardiopathy and stroke.

  • Multiple risk management
  • Primary Hypertension
  • Secondary Hypertension
  • Isolated systolic Hypertension
  • Malignant Hypertension
  • Resistant Hypertension
  • Pathophysiology of Hypertension

Track 2:  Pulmonary Hypertension

Pulmonary Hypertension or PH is high blood pressure that affects the arteries in the lungs and the right side of the heart. In one form of pulmonary hypertension, tiny arteries in the lungs and capillaries become narrowed, blocked or destroyed. This makes it harder for blood to flow through the lungs and thus raises the pressure within lung walls. As the pressure builds, the heart's lower right chamber works harder to pump blood through the lungs, eventually causing the heart muscle to fail. Some forms of pulmonary hypertension are serious conditions that become progressively worse and are sometimes fatal. This session mainly talks about the classification, signs, symptoms, and treatments of Pulmonary Hypertension.

  • Classification of Pulmonary Hypertension.
  • Signs, symptoms and causes of Pulmonary Hypertension.
  • Diagnosis by Echocardiography
  • Treatment and Therapies

 Track  3  : Pediatrics Hypertension

Pediatric  hypertension inclines to hypertension and cardiovascular malady in grown-up life. Despite clear rules, there remains an absence of screening. Determination stays testing given the high rate of false-positive hypertension (BP) readings at a solitary visit; along these lines, different visits are required to affirm the analysis. 

  • Incidence of hypertension in childhood  
  • Epidemiology of hypertension in children
  • Treatment and management of Pediatric Hypertension
  • Cardiovascular risk factors & complications
  • Pathophysiology of pediatric hypertension

Track 4: Gestational Hypertension

Hypertension is that the development of recent cardiovascular disease in a very pregnant lady when twenty weeks gestation while not the presence of supermolecule within the excretory product or different signs of   Pre-eclampsia.  It's a brief identification for hypertensive pregnant ladies who don't meet criteria for pre-eclampsia or chronic cardiovascular disease. The identification is modified to, pre-eclampsia if a symptom or new signs of end-organ pathology develop and chronic cardiovascular disease if blood pressure eleatally

  • Classification of Gestational Hypertension
  • Risk factors for Gestational Hypertension
  • Pre-eclampsia and eclampsia
  • Pathogenesis of pre-eclampsia
  • Management and Drug Treatment of Hypertension in pregnancy

Track 5:  Hypertension and Cardiac Arrest

 Cardiac arrest  can be defined as a sudden stop in effective blood flow due to the failure of the heart. It is caused when the heart's electrical system malfunctions. The individual section in the session talks about all the related heart diseases. In cardiac arrest death results when the heart suddenly stops working properly. This may be caused by abnormal, or irregular, heart rhythms, cardiomyopathy (A thickened heart muscle), Heart medications, Electrical abnormalities, Recreational drug uses. Some symptoms of the arrest could be a sudden loss of responsiveness, abnormal breathing, fainting, fatigue, blackouts, dizziness, chest pain, shortness of breath, weakness, and vomiting. The most common cause for Cardiac arrest is the coronary heart disease. Coronary artery disease often results coronary ischemia and ventricular fibrillation

  • Causes of Cardiac Arrest Due to Hypertension
  • Indications and Symptoms
  • Diagnostics for The Arrest
  • Treatment for Cardiac Arrest during Hypertension

Track 6:   Hypertension and Obesity

 Hypertension refers to the pressure that blood applies to the inner walls of the arteries. Obesity  increases the chances of cardiovascular disease. The individual session in this focuses on obesity-related cardiovascular disease, its interaction with the outcomes of hypertension, risk factors, treatment and management of cardiovascular disease. Obesity-associated arterial hypertension is characterized by activation of the sympathetic system, activation of the renin-angiotensin system and sodium retention, among different abnormalities   Anti-hypertension   medications ought to be started if hypertension is diagnosed. But, with weight-loss, a major fall in force per unit area could allow a decrease within the range of medicines taken or decrease the quantity of medication taken. Prevention would be better than any drug .  

  • Obesity-associated Arterial Hypertension
  • Incidence of Hypertension and Obesity
  • Pathophysiology of Obesity-Related Hypertension
  • Interaction of Obesity With Consequences of Hypertension.
  • Prevention & Management of Weight Gain and Hypertension
  • Therapies to treat obesity-related hypertension

Track 7: Hypertension – Stress and Stroke

 Stressful situations can lead the blood to spike up temporarily but sometimes it may cause high blood pressure too. Research is still in progress to find out about it. According to some reports, the change in the blood pressure behavior can be due to various habits like overeating, drinking or poor sleeping. It’s possible that health conditions related to stress like anxiety, depression, and isolation from friends and family may lead to heart disease but not to a high blood pressure condition. Some hormonal changes may damage your arteries leading towards heart disease. According to the National Health Interview Survey, almost 75% of the general population experiences some stress every week.  A stroke occurs when a blood vessel to the brain is either blocked by a clot or bursts, a part of the brain stops to get the required amount of blood and oxygen and hence it starts to die. Since the brain controls the entire body so it can threaten one’s ability to think, move and function. Hence Hypertension is the most prevalent and powerful modifiable risk factor for stroke           

Track 8:  Hypertension and diabetes

Hypertension can lead to many complications of Diabetes. Most people affected with Diabetes are more prone to suffer Hypertension. Diabetes damages the arteries and makes them targets for hardening  and if it is not treated then it may also cause blood vessel damage, heart attack, and kidney failure too. In this section of the main, we discuss various types of Diabetes, risk factors that are involved in it, controlling hypertension in patients with Diabetes and Treatment. 

  • Classification of Diabetes
  • Risk factors for Diabetes
  • Treatment and Therapies

Track 9: Diet and Exercise for Hypertension

High blood pressure ,which is also called hypertension increase the risk of developing many serious health problem  including heart disease, stroke, and kidney disease. Evaluation and Treatment of High Blood Pressure recommendations have defined   hypertension” as a BP of ≥140/90 mm Hg. The risk of cardiovascular disease n the patient with hypertension can be greatly reduced with effective antihypertensive therapy. Maintaining normal body weight, following a proper diet plan, exercising regularly, avoiding high-sodium content foods, limited alcohol consumption and pressure account.

  • Etiology of renal failure

Track 10:  Hypertension Treatments

 High blood pressure can be cured. The disease can be controlled by following a proper and healthy lifestyle. As per recommended by various doctors by having a healthy lifestyle, eating less salt in your regular diet, quitting smoking, consuming the limited amount of alcohol can help in curing the disease. In addition to this regular exercise will also help in controlling the disease. Drug treatments are available too for Hypertension. Various drugs are available in the market that allows the individual person to do that in which few are-Thiazide diuretics, Beta blockers, Angiotensin II receptor blockers (ARBs), Calcium channel blockers, Central-acting agents, Alpha blockers, Aldosterone antagonists.

  • Pharmacology and toxicology of anti hypertensive drugs
  • Homeopathic
  • Treatment for Hypertension

Track 11:  Advance treatment approches

Treating high blood pressure can take a multi-pronged approach including diet changes, medication, and exercise. Hypertension, or high blood pressure, is dangerous because it can lead to strokes, heart attacks, heart failure, or kidney disease. The goal of hypertension treatment is to lower high blood pressure and protect important organs, like the brain, heart, and kidneys from damage. Treatment for hypertension has been associated with reductions in   stroke ,   heart, and heart failure according to research. Because   hypertension rarely causes specific symptoms, it is not identified until an individual’s blood pressure is measured by a physician or it causes a catastrophic complication such as stroke or heart attack. Accurate diagnosis by blood pressure measurement is essential

Track 12:   Clinical Case Report

High blood pressure, also known as hypertension, affects millions, even children and teens. It is a common condition that catches up with most people who live into older age. The exact cause of hypertension is unknown, but there are several factors and conditions that may contribute to its occurrence. In the USA about 82% of the total population is suffering from hypertension.

Track 13: Causative Factors and Risk Assessment

High blood pressure  has several causative factors like age, race, case history and obesity, not being physically active, overwhelming tobacco, an excessive amount of salt (sodium) in diet, deficient Vitamin D in the diet, drinking an excessive amount of alcohol, stress and bound chronic conditions. Though high pressure is commonest in adults, youngsters are also in danger, too. For a few youngsters, high pressure is caused by issues with the kidneys or heart except for a growing variety of youngsters, poor fashion habits, like an unhealthy diet, fleshiness, physiological condition and lack of exercise contributes to high pressure

  • Multiple risk management
  • Controllable risk factors
  • Uncontrolled risk factors
  • Global Cardiolgy

 

 

Market analysis

Importance and Scope:

Hypertension is a major menace factor for cardiovascular diseases, cerebrovascular events and ischemic heart diseases, thereby  considered as one among the most imperative inevitable causes of premature morbidity and mortality in the world. It is often symptomless, so screening is vital before harm is done. Many surveys show that hypertension remains underdiagnosed, untreated and poorly controlled. On the whole, the prevalence of hypertension (at least ≥140/90 mm Hg or on treatment) in those aged over 35 was observed to be 32% in men and 27% in women.

Hypertension Congress 2020  provides an international platform for presenting researches about Hypertension and related concepts, sharing alternative ideas about the severe cardiovascular risk factor, contributing to the dissemination of information about the trouble for the welfare of the society.

Why Japan?

Japan’s ability to conduct independent research is a decisive factor in boosting nation’s competitiveness. A place for conducting good research for hypertension and cardiovascular research which have institutes like Advanced Medical Research Centers, National Institutes for Basic Biology and many more centers that are handy. Most of the researches Japan undergoing are based on Clinical Research which includes Clinical and pre-clinical Trials. With 5% of GNP, Japan is unique with its science and the availability of raw materials to industrial companies offers them excellent research opportunities.

 

Societies Associated with Hypertension

  • Arun dal heart associates
  • Cardiology Associates, LLC Annapolis
  • Cardiovascular Specialists of Frederick
  • Chesapeake and Washington Heart Care, PC
  • Chesapeake Cardiovascular Associates- Woodholme
  • Cardiology Associates, LLC Kent Island
  • Child Cardiology Associates
  • Delaware Cardiovascular Associates Elkton Office
  • Patuxent Cardiology Associates
  • Steward Physician Network, Inc.
  • Suburban Cardiology and Internal Medicine, PC
  • Steward Medical Group, LLC
  • The Cardiovascular Specialists.

Hospitals Associated with Hypertension

  • American Cardiology and Nuclear Practice
  • BehringHospital Vall D'Hebron, Laboratorio ecocardiografia, Barcelona
  • Cardiology and Internal Medicine PA
  • Cardiology Center
  • Cardiovascular Center Of Hagerstown
  • Cardiovascular Diagnostic Center, PA
  • Columbia Cardiac Care
  • AMG Cardiovascular Consultants
  • Calvert Cardiology Clinic
  • Cardio Care, LLC
  • Coronary Artery Disease NSC "The M. D. Strazhesko Institute of Cardiology" Kiev
  • Delmarva Heart, LLC
  • Doctors Community Hospital
  • Suburban Cardiology and Internal Medicine, PC
  • Taunton Satellite Office
  • The Cambridge Hospital
  • The Heart Center of Metro West
  • The Plymouth Heart Center
  • Tufts Medical Center
  • UMass Memorial Medical Health Care-Memorial Campus
  • UMass Memorial Health Care Cardiac Ultrasound Laboratory
  • West Roxbury Veterans Affairs Medical Center
  • Winchester Hospital Echocardiography Laboratory
  • WPA-Woburn Medical
  • Whidden Hospital
  • Winchester Cardiac Ultrasound

 

Past Conference Report

Hypertension Congress 2018

We would like to thank all our delightful speakers, students, associations and guests for making Hypertension congress 2018 a wonderful event!

Thank you for being a part in the 3rd  International Conference on Hypertension & Healthcare (Hypertension Congress 2018).

It was a immense pleasure seeing many well-known faces, and many others who have just joined the Hypertension Congress 2018 at the Radisson  Narita, Tokyo, Japan

We hope you had a remarkable time at the conference.

Thank you to all the Honorable Guests, Keynote Speakers, Moderator, Chairs, Co-Chairs, Speakers, Students and Delegates, the Organizing Committee and Editorial Board members for their support. The conference would not have been the same without each one of you. We enjoyed hosting the event and hope you walked away with new ideas, inspiration and ambition to promote work in all possible ways.

Conference series llc LTD played host to diverse panel of key members of the Hypertension community from research lab, industry, academia and financial investment practices, discussing the future of Hypertension specialties. This event was really aimed for examining where the real Hypertension specialties are going in the future and purpose of the event was to provide an opportunity for cross fertilization of ideas and development of ideas, in the field of Hypertension.

Focusing on Hypertension & ObesityHypertension Risk factorsHypertension DiagnosisGestational HypertensionHypertension ManagementCase Reports & Hypertension Epidemiology as well, the two days of discussions enabled professionals to gain a perception into the current advances and opened networking opportunities.

The highlights of the meeting were the eponymous lectures, delivered by Nditsheni Ramakuela from University of Venda, South Africa, Christopher Elliott Leman Micro Devices SA, Switzerland, Muhammad Nabeel Dookhun, Nanjing Medical University, China , These talks were of great interest to the general cardiologists and were enormously informative.

Conference series llc LTD 3rd International Conference on Hypertension & Healthcare was a great success with the support of international, multi professional steering committee and coordinated by the Journal of Clinical & Experimental Cardiology, Journal of Hypertension: Open Access, Journal of Cardiovascular Diseases & Diagnosis and Cardiovascular Pharmacology: Open Access.

Hypertension 2017

Thanks to all of our wonderful speakers, conference attendees of Hypertension 2017 Conference were our best ever!

2nd International Conference on Hypertension & Healthcare was held during September 11-13, 2017 Amsterdam, Netherlands with the theme “New insights in diagnosis and management for hypertension”. Benevolent response and active participation from the Scientists, Doctors, Professors, Pharmaceutical Industries, Healthcare Industries, Researchers and Students from the fields of cardiology and healthcare who made this event successful.

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks: Hypertension, Hypertension & Obesity, Renal Hypertension, Pulmonary Hypertension, Gestational Hypertension, Hypertension & Stroke, Causative Factors and Risk Assessment, Diagnosis and Pathophysiology of Hypertension, Pharmacologic and Other Treatments for Hypertension, Diet and Lifestyle in Hypertension Management, Hypertension Epidemiology, Advanced Treatment Approaches, Clinical Case Reports

Hypertension 2017 Organizing Committee would like to thank the Moderators of the conference – Dr. Fabiola B Sozzi, University of Milan, Italy and A.J. van Ballegooijen, VU University, The Netherlands

The conference was initiated with a warm welcome note from Honorable guests and the Keynote forum lead by Dr.Michiel Voskuil from Universitair Medisch Centrum Utrecht, The Netherlands and Dr. Attila Kardos from Milton Keynes University Hospital, UK and Igor I Tulevski from Cardiology Centra Nederland, The Netherlands

The highlights of the meeting were the eponymous lectures, delivered by:

  • Dr. Fabiola B Sozzi, University of Milan, Italy
  • Hossein Tabriziani, Loma Linda University, USA
  • Valéria Paula S. Fazan, University of Sao Paulo, Brazil
  • Nilda Gladys Espinola-Zavaleta, National Institute of Cardiology Ignacio Chavez, Mexico
  • Patricia Hidalgo M, San Ignacio-Pontificia Universidad Javeriana, Colombia
  • Alan Fleming, Optos, UK
  • Louis Peeters, Utrecht University, The Netherlands
  • Marc Spaanderman, Maastricht University, The Netherlands
  • Johannes J. (Hans) Duvekot, Erasmus University, The Netherlands
  • Peter de Leeuw, Maastricht University, The Netherlands
  • Faezeh Sahbaeiroy, Iran
  • Bum Ju Lee, Korea Institute of Oriental Medicine, Republic of Korea
  • A.J. van Ballegooijen, VU University, The Netherlands
  • Fatemeh Esfarjani, Shahid Beheshti University of Medical Sciences, Iran
  • Amar Mohanrao Taksande, Jawaharlal Nehru Medical College, India
  • Soha M Abd El Dayem, National Research Centre, Egypt
  • Ahmed A Battah, Cairo University, Egypt

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums at Hypertension 2017. We sincerely thank the Organizing Committee Members, Editorial Board Members of International Journals, Participants, Attendees and Media Partners for their gracious presence and generous support, without which the conference would not have reached the pinnacle of success. With the unique feedback from the conference, we would like to announce the commencement of the 7th International Conference on Hypertension & Healthcare during June 10-11, 2019 at Helsinki, Finland.

 


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date March 25-26, 2020

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Supported By

Journal of Hypertension Journal of Cardiovascular Diseases & Diagnosis Journal of Clinical & Experimental Cardiology

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by